1. Home
  2. CLMB vs ALT Comparison

CLMB vs ALT Comparison

Compare CLMB & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$22.64

Market Cap

387.6M

Sector

Technology

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.61

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMB
ALT
Founded
1982
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.6M
421.5M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
CLMB
ALT
Price
$22.64
$2.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$80.00
$17.67
AVG Volume (30 Days)
128.7K
2.6M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.60%
N/A
EPS Growth
14.29
25.37
EPS
0.18
N/A
Revenue
$652,517,000.00
$41,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.83
N/A
P/E Ratio
$128.89
N/A
Revenue Growth
40.14
105.00
52 Week Low
$15.25
$2.56
52 Week High
$145.00
$7.73

Technical Indicators

Market Signals
Indicator
CLMB
ALT
Relative Strength Index (RSI) 49.85 36.34
Support Level $18.97 $2.56
Resistance Level $23.60 $4.19
Average True Range (ATR) 1.17 0.12
MACD 0.50 -0.03
Stochastic Oscillator 50.86 9.79

Price Performance

Historical Comparison
CLMB
ALT

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: